학술논문

Risk of diverticulitis and gastrointestinal perforation in rheumatoid arthritis treated with tocilizumab compared to rituximab or abatacept
Document Type
Article
Source
In: Rheumatology (United Kingdom). (Rheumatology (United Kingdom), 1 March 2022, 61(3):953-962)
Subject
Language
English
ISSN
14620332
14620324